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Abstract: One of the compounds suggested to be responsible for the cyanobacterial dominance over 
competing green algae is identified. Evidence is provided on the molecular, chemical level that the iron 
chelator anachelin from the cyanobacterium Anabaena cylindrica promotes both the growth of 
cyanobacteria and reduces the growth of competing chlorophytes. These results illustrate a molecular 
strategy of addressing two challenges (nutrient availability and algal competition) by one molecule. 
Such strategies could be implied in harmful algal blooms in marine and freshwater environments. 
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Introduction 
The growth of phytoplankton has direct 
implications to fields such as global carbon 
budgeting, climate regulation and for fisheries 
through its central role in both marine and 
freshwater ecosystems.[1] The growth of 
prokaryotic cyanobacteria and eukaryotic algae is 
determined by resource limitations including light, 
inorganic and organic nutrients, the attack of 
grazers and pathogens, and interspecific 
inhibition through allelochemicals.[2] The 
importance of phosphorous and nitrogen has 
been well documented, and recently also the 
impact of iron on phytoplankton growth has found 
new interest.[3-5] Whereas iron is one of the 
most abundant elements on earth, its 
bioavailability is very low due to the prevalence of 
insoluble iron oxide hydrate species.[6,7] 
Cyanobacteria have met this challenge by 
producing small molecule iron chelators called 
siderophores.[8-10] Over sixty years ago, Fogg 
FULL PAPER HELVETICA CHIMICA ACTA  
2 
and Westlake suggested that cyanobacteria 
secrete siderophores that “may have important 
effects on the growth of organisms in the 
water”.[11] This hypothesis was expanded by 
Tassigny and Lefèvre, who raised the possibility 
of allelochemical action of such secreted 
compounds in cyanobacterial and algal 
blooms.[12] 
Murphy and co-workers,[13] and more recently 
Matz and co-workers,[14] provided further 
experimental support and concluded that the 
excretion of siderophores by species of the 
cyanobacterium Anabaena enables other 
cyanobacteria to grow, to outcompete, and thus 
to dominate eukaryotic algae. So far only 
supernatants of cultures or crude extracts were 
studied.[11-14] In particular, the presence of 
additional unrelated allelopathic compounds was 
never ruled out and the responsible compounds 
were never characterized on the molecular level. 
Anachelin (1) was isolated from the 
cyanobacterium Anabaena cylindrica and 
features an interesting structural diversity 
combining polyketide, peptide and alkaloid 
fragments (Figure 1).[15] We have studied its 
conformation,[16] suggested a biogenetic 
hypothesis[17] and established the configuration 
by total synthesis.[18] However, up to now, no 
biological studies of this metabolite have been 
reported. In particular, while the catecholate unit 
(green in 1) is proposed to facilitate iron uptake 
and can be used to functionalize surfaces, the 
role of the polyketide fragment (red in 1) 
remained unknown.  
Herein, we provide evidence through chemical 
synthesis combined with growth experiments that 
the cyanobacterial siderophore anachelin (1)[15] 
enhances growth of the cyanobacterium 
Microcystis aeruginosa concomitant with 
allelopathic activity against the competing green 
alga Kirchneriella contorta. We devised a new 
synthetic route based on several organocatalytic 
transformations to the polyketide fragment of 
anachelin, and through the synthesis of additional 
derivatives, the structural elements in anachelin 
(1) that are responsible for this dual mode of 
action have been identified. Anachelin (1) thus 
presents a fully elucidated example of a 
cyanobacterial siderophore with allelopathic 
properties against competing photoautotrophic 
microorganisms (dual mode of action). 
 
Results and Discussion 
Synthesis: In order to study the effects of the 
constitution and configuration of anachelin (1) on 
biological activity, anachelin (1), three truncated 
derivatives 2-4 and two epimers 5 and 6 Figure 
1) were prepared by chemical synthesis. As a 
representative of the alkaloid fragment, Boc-
protected anachelin chromophore 2 was 
prepared in 8 steps starting from L-dopa using an 
oxidative aza-annulation as the key step.[17,19] 
The peptide fragment 3 was synthesized by 
debenzylation of a protected analog previously 
reported by us.[18] In order to block the 
otherwise free terminal amino group and mask 
unwanted reactivity, the chemically inert 
butyloxycarbonyl (Boc) group was introduced in 
fragments 2 and 3. The preparation of 
diastereoisomers 5 and 6 was carried out using 
previously reported building blocks.[18] 
 
Figure 1. Anachelin (1), fragments 2-4, and 
diastereoisomers 5 and 6. 
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Scheme 1. The organocatalytic approach to the 
polyketide fragment 4. 
The polyketide fragment 4 was addressed next, 
and although we have developed routes to this 
unit,[18,19] we needed an optimized process to 
secure amounts for biological testing. Therefore, 
a concise approach featuring organocatalytic key 
steps was developed for the synthesis of the 
challenging polyketide fragment 4. The synthesis 
commenced with the addition of allylmagnesium 
chloride to Garner’s aldehyde (7)[20] (Scheme 1). 
Unfortunately, the chiral substrate was unable to 
induce good selectivity in the addition step and 
3:1 mixture was obtained in favor of desired 
diastereoisomer. Thus, we utilized the reliable 
Duthaler-Hafner method that results excellent 
yield and selectivity for the allyl alcohol 8 (87%, 
dr >20:1).[21] The chiral allyl alcohol 8 was then 
protected, and silylated 9 was subjected to cross 
metathesis with crotonaldehyde to the -
unsaturated aldehyde 10 in good yield (93% over 
two steps). We then envisioned the use of an 
organocatalytic approach for the installation of 
the -hydroxy group and oxidation of the 
aldehyde to the ester.[22] In the first step, a 
catalyst controlled asymmetric epoxidation was 
performed with the proline–derived secondary 
amine catalysts B and C.[23] Sterically 
demanding catalyst  B resulted in good selectivity 
with moderate yield, whereas slightly diminished 
selectivity but good yield was obtained with 
biphenyl-substituted catalyst C. The chiral epoxy 
aldehyde was then directly subjected to the N-
heterocyclic carbene (NHC) catalyzed internal 
redox process in the same pot.[24] In situ 
generated NHC by deprotonation of 
corresponding azolium ion D facilitates the 
epoxide opening followed by esterification to yield 
ester 11 in good yield and selectivity. 
 
 
Scheme 2. Completion of the synthesis of polyketide 
fragment 4. 
We then proceeded with the synthesis and silyl 
protection of the free OH group, which delivered 
the fully protected ester 12 (Scheme 2). The next 
task was the introduction of the amide 
functionality after selective deprotection of Boc-
group. After some unsuccessful attempts using 
Lewis acids (AlCl3) or stronger Brønsted acids 
(HCl), it was found that both the acetonide and 
Boc group can be cleaved using a mixture of 
CH2Cl2 and CF3CO2H at 0 °C for 1h. Undesired, 
desilylated product formation was observed by 
carrying out the reaction at higher temperature 
and upon longer reaction time. The amino alcohol 
was then subjected to amide coupling employing 
EDC.HCl and HOBt as coupling reagents to give 
13. Finally, removal of the protecting groups by 
sequential hydrogenation and acid mediated 
desilylation completed the synthesis of target 
compound 4 in 9 steps and 40% overall yield 
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starting from Garner’s aldehyde. This route 
therefore allowed for the generation of sufficient 
material for subsequent biological testing, which 
was carried out next. 
 
Effect of Anachelin on Growth of Microcystis 
aeruginosa: We first wanted to evaluate the 
effect of the siderophore anachelin (1) on the 
growth of other cyanobacteria. Therefore, we 
investigated the growth inducing properties of 
anachelin (1), the siderophore of Anabaena 
cylindrica,[15] on a bloom-forming 
cyanobacterium (Microcystis aeruginosa). We 
prepared synthetic anachelin,[18] which was 
shown to be spectroscopically identical to a 
natural sample and, in particular, free of any 
cyanobacterial toxins potentially associated with 
natural samples. The addition of anachelin (1) 
promoted growth of the toxic cyanobacterium M. 
aeruginosa in a dose-dependant manner (Figure 
2). Small amounts of anachelin (starting at 800 
nM concentration) were sufficient to lead to a 
significant higher growth compared to the control. 
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Figure 2. Growth of Microcystis aeruginosa (grown in 
0.1 µM Fe-citrate) before and after addition of 
anachelin (1). Anachelin was added in 4 different 
concentrations (0.08; 0.8; 8; 80 µM) at 124.5 h. Error 
bars indicate the standard deviation of three replicates. 
Having established a positive impact of anachelin 
(1) on M. aeruginosa, we wanted to investigate a 
variety of concentrations of both siderophore and 
Fe (Figure 3). This beneficial effect on 
cyanobacterial growth was further substantiated 
at two different Fe concentrations in the medium 
(0.1 μM and 10 μM), but the observed effects 
decreased with increasing iron concentration 
(Figure 3A and 3B), likely due to higher growth 
rates of M. aeruginosa. Whereas at lower iron 
concentration an almost fivefold increase in 
growth compared to control could be observed, 
the increase at higher iron concentrations in the 
medium was only twofold. The reason for this 
growth enhancing property is likely to reside in 
the binding of iron by the siderophore resulting 
thus in higher bioavailability of iron to the 
cyanobacterium. M. aeruginosa itself is known to 
produce hydroxamate-type siderophores.[25] 
However, the phenomenon that microbes can 
uptake siderophores they do not produce by 
themselves is well known and was described as 
‘siderophore piracy’.[26] In addition, it could be 
demonstrated that uncultured bacteria were 
enabled to grow via the secretion of siderophores 
of a distantly related and previously cultured 
bacterium.[27] Additionally, it was shown that 
within the genome of some bacteria the number 
of siderophore uptake genes is much higher than 
the number of synthesis genes.[28] From all 
these findings it can be concluded that the 
inability to produce siderophores and thus the 
dependence on other organisms might allow 
microbial growth to establish a community only in 
an environment with favored neighbours.[27] 
Although only known from heterotrophic bacteria 
so far, a similar ‘siderophore piracy’ might also 
take place in cyanobacteria. Still it is unknown 
whether the iron-anachelin complex delivers iron 
directly or through a specific transporter into the 
Microcystis cell. However, it seems that M. 
aeruginosa is a strong competitor under iron 
limitation.[25]  
In a first conclusion, these experiments 
demonstrate that anachelin (1) is not only able to 
enhance growth of its producer,[15] but also to 
enhance growth of other cyanobacteria such as 
M. aeruginosa, likely via facilitated Fe uptake by 
chelation. 
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Figure 3. Growth of the cyanobacterium Microcystis 
aeruginosa 310 h after addition of six different 
concentrations of anachelin (1). Error bars indicate the 
standard deviation of three replicates. Asterisks above 
bar indicate that the concentration of anachelin 
significantly promoted the growth of M. aeruginosa 
compared to the control (p < 0.05; tested by ANOVA, 
followed by Dunnett’s post hoc tests). (A) M. 
aeruginosa grown in 0.1 µM Fe-citrate; (B) M. 
aeruginosa grown in 10 µM Fe-citrate. 
 
Effect of Anachelin (1) on Growth of 
Kirchneriella contorta: We then investigated the 
action of anachelin on a competing planktonic 
green algae (chlorophyte, Kirchneriella contorta). 
Anachelin (1) inhibited the growth of this species 
in a dose-dependant manner, starting at 
nanomolar concentrations; a significant impact 
could be observed at low micromolar 
concentrations (Figure 4). This effect was not due 
to iron sequestering by anachelin, as this 
allelopathic effect was also found to be present at 
a large excess of iron: at 10 M total Fe(III) 
concentration, nanomolar concentrations of 
anachelin were sufficient to negatively impact the 
growth of the green algae (Figure 4). A growth 
reduction of 15% was already observed at 900 
nM concentrations; at 60 M a growth reduction 
of 33% was found. From these experimental data, 
it can be concluded that this allelopathy is most 
likely independent of iron concentration, thus 
questioning the ‘iron monopoly’ hypothesis,[13] 
and adding support to the hypothesis of 
additional inhibitory activity unrelated to iron 
chelation. Matz and co-workers could show that 
siderophores derived from Anabaena flos-aquae 
inhibited the growth of the green alga 
Chlamydomonas reinhardtii via uncharacterized 
toxicity in iron-limited medium but not due to 
competition of iron.[14] Additionally, we observed 
a significant growth inhibitory effect of anachelin 
against Chlamydomonas which reflects its 
general allelopathic activity (see supporting 
information). 
Taken together, these results provide evidence 
that anachelin (1) is able to promote the growth 
of the cyanobacterium M. aeruginosa, and that 
this natural product inhibits the growth of two 
competing green algae. Such a dual mode of 
action for an iron chelator is surprising. We then 
wanted to evaluate the structural requirements 
for these effects, and in particular, find out if 
certain fragments of anachelin (1) were 
responsible for this divergent activity. 
 
 
Figure 4. Reduction of growth of the green alga 
Kirchneriella contorta 316 h after addition of six 
different concentrations of anachelin (1). K. contorta 
was grown in 10 µM Fe-citrate. Error bars indicate the 
standard deviation of three replicates. Asterisks above 
bar indicate that the concentration of anachelin 
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significantly inhibited the growth of K. contorta 
compared to the control (p < 0.05; tested by ANOVA, 
followed by Dunnett’s post hoc tests). 
 
Effect of Fragments on Growth of 
Kirchneriella contorta: In order to investigate 
the chemical mode of action of this allelopathic 
activity, and to identify the structural 
requirements, derivatives 2-4 of anachelin (1) 
were tested for the growth inhibition of K. 
contorta (Figure 5). First we investigated the role 
of the quaternary ammonium functionality, which 
is known for manifold biological activities 
including potent antibacterial and antifungal 
properties.[29] Fragment 2 was in principle able 
to inhibit the growth of the green algae but not to 
the same extent as the anachelin itself. At a very 
high concentration of 60 M fragment 2 reduced 
the growth of the green algae of about 17% 
(Figure 5A). Virtually the same inhibition effect 
was observed with anachelin (1) already at high 
nanomolar concentrations that is two orders of 
magnitude lower. Several quaternary ammonium 
compounds have been found to negatively effect 
the growth of green algae such as Scenedesmus 
intermedius, Dictyosphaerium chlorelloides, and 
Pseudokirchneriella subcapitata.[30] Thus, it is 
possible that the quaternary ammonium group of 
fragment 2 supported the total activity of 
anachelin, but to a minor extent. In contrast, 
fragment 3 did not have any negative impact on 
the growth of K. contorta, even at very high 
concentrations (Figure 5B). At two concentrations, 
a significant positive effect was observed, but the 
overall tendency was not different from the 
control. Comparing the fragments 2 and 3 one 
can speculate, that the impact of the quaternary 
ammonium, if bound to the tripeptide as in 
fragment 3 or in anachelin (1), is negligible for the 
overall growth inhibitory effect of anachelin. 
 
 
Figure 5. Growth of Kirchneriella contorta 310 h after 
addition of six different concentrations of different 
fragments. K. contorta was grown in 10 µM Fe-citrate. 
Error bars indicate the standard deviation of three 
replicates. Asterisks above bar indicate that the 
concentration of the fragments significantly inhibited or 
promoted the growth of K. contorta (p < 0.05; tested by 
ANOVA, followed by Dunnett’s post hoc tests). (A) 
Addition of fragment (2); (B) Addition of fragment (3); 
(C) Addition of fragment (4). 
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Cyanobacteria are well recognized for the 
production of polyketides with broad biological 
activities.[31] In a next experiment, the polyketide 
fragment 4 of anachelin as prepared through the 
organocatalyic route above, was tested for the 
growth inhibitory effect on K. contorta. The 
polyketide inhibited the growth of the green algae 
in a dose-dependant manner, starting at 
nanomolar concentrations (Figure 5C). A 
significant impact could be observed at low 
micromolar concentrations. At 60 μM a growth 
reduction of 38% was observed. Thus, the impact 
of fragment 4 on the growth of the green algae 
resembled the one of anachelin (1). It can be 
concluded that virtually the complete antialgal 
activity was retained in the polyketide fragment 4 
(Figure 5). 
 
Effect of Diastereoisomers on Growth of 
Kirchneriella contorta: We next investigated 
whether this inhibitory and allelopathic activity is 
unrelated to iron binding. Therefore, two 
diastereoisomers of anachelin, i.e. compounds 5 
and 6 were evaluated, that are still able to bind 
iron, but differ in the configuration of the 
polyketide fragment. Interestingly, both the 3,5-
epi-anachelin (5) and the 3,5,6-epi-anachelin (6) 
were hardly affecting the growth of K. contorta 
(Figure 6). Only the 3,5-epi-anachelin showed a 
growth reduction of 12% at high (60 M) 
concentrations. Additionally, using 3,5,6-epi-
anachelin, the molecule in which the 
configuration of all three hydroxy groups of the 
polyketide was inverted, no significant growth 
inhibition could be observed. This demonstrates 
that the relative configuration in the polyketide 
fragment of anachelin is crucial for allelopathic 
activity and that the observed growth inhibitory 
activity is unrelated to iron binding and 
siderophore activity. 
 
 
Figure 6. Growth of Kirchneriella contorta 310 h after 
addition of six different concentrations of the 
diastereoisomers. K. contorta was grown in 10 µM Fe-
citrate. Error bars indicate the standard deviation of 
three replicates. Asterisks above bar indicate that the 
concentration of the diastereoisomers significantly 
inhibited the growth of K. contorta (p < 0.05; tested by 
ANOVA, followed by Dunnett’s post hoc tests). (A) 
Addition of 3,5-epi-anachelin (5). (B) Addition of 3,5,6-
epi-anachelin (6). 
 
The Dual Mode of Action: All these results 
provide strong evidence on a molecular level that 
the siderophore anachelin possesses a dual 
mode of action both promoting the growth of 
cyanobacteria and concomitantly inhibiting the 
growth of competing phytoplankton. The two 
bioactivities are promoted by different fragments 
of the same molecule: whereas the 
tetrahydroquinolinium fragment (shown in green 
in 1) binds iron[18] and is thus mainly considered 
responsible for growth promotion, the polyketide 
fragment (shown in red in 1) is responsible for the 
allelopathic growth inhibition. It is interesting to 
note that the different bioactivities reside in 
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fragments that might have different biosynthetic 
origins: The iron binding in the alkaloid part and 
the allelopathic activity in the polyketide fragment. 
As anachelin can be considered a product of 
mixed polyketide synthase and non-ribosomal 
peptide synthetase pathways, it can be 
speculated that these fragments, and thus the 
corresponding activities, have biosynthetically 
merged over time in one single compound. These 
experimental findings for a cyanobacterium are 
complemented by dual mode of action hybrids 
(sideromycins) isolated from bacteria, where both 
iron chelating and antibiotic fragments are 
complementary present.[32] In addition, 
anachelin (1) provides an interesting example of 
natural product with two different fragments 
merged. While many natural products can be 
structurally simplified,[33] in this case, one 
biological property would be lost. Based on 
structural considerations, such combined 
fragments having different functions could be 
operative in other natural products from 
cyanobacteria, such as the cyanopeptolins or the 
aeruginosins.[34] 
Possible Role of Anachelin in the 
Environment: In the ecological context, it should 
be pointed out that the producer of anachelin, 
Anabaena cylindrica, is a filamentous freshwater 
cyanobacterium that can form biofilms and can 
occur also as planktonic organism in ponds and 
small lakes. In such densely populated 
environments, where cooperative behavior may 
be successful, secreted iron chelators are likely 
to be taken up by other cells of the filament or by 
other filaments thus increasing the overall 
amount of bioavailable iron. At the same time, the 
anachelin that is lost by diffusion can be 
predicted to display a secondary benefit by 
inhibiting the growth of competing organisms like 
eukaryotic algae. By using one secondary 
metabolite, Anabaena cylindrica can address two 
main challenges related to phytoplankton growth, 
i.e. nutrient limitation and inhibition of competitors.
Conclusions 
In conclusion, we have shown that the iron 
chelator anachelin (1) stimulates growth of 
Microcystis aeruginosa while at the same time 
reducing the growth of two competing green 
algae, i.e. Kirchneriella and Chlamydomonas. 
Chemical synthesis of the derivatives such as 2-4 
and diastereoisomers such as 5 and 6 allowed 
for the identification of the crucial fragment for 
this activity, where the polyketide moiety was 
shown to be responsible for allelopathy. 
Anachelin (1) can thus be considered a molecular 
hybrid with a dual mode of action. These 
experiments described herein provide therefore 
detailed experimental evidence for theories 
documented over the last 50 years regarding the 
role of iron chelators related to algal blooms.[11-
14] 
The data presented in this study provide a strong 
rationale on a molecular level for the hypothesis 
that the excretion of iron chelators such as 
anachelin constitutes a strategy of cyanobacteria 
to dominate competing species. 
Experimental Part 
Abbreviations. Boc = tert-butoxycarbonyl; CDI = 
carbonyldiimidazole; DMAP = N, N-
dimethylaminopyridine; EDC = ethyl-(N, N-
dimethylaminopropyl)car-bodiimide; ether refers to 
diethylether; FC = flash chromatography; HOBt = 1-
hydroxybenzotriazole; NMM = N-methyl-morpholine; 
RT = room temperature; TBS = tert-butyl-dimethylsilyl; 
TFA = trifluoroacetic acid; THF = tetrahydrofuran; THQ 
= 3-amino-6,7-dihydroxy-1,1-dimethyl-1,2,3,4-
tetrahydro-quinolinium; Z = benzyloxycarbonyl. 
Unless otherwise stated, chemicals were purchased 
from Sigma-Aldrich, ABCR, Acros or Lancaster and 
used without further purification. Solvents for work-up 
and chromatography were distilled from technical 
quality. Solvents used for chemical transformations 
were either puriss quality or dried by filtration through 
activated aluminium oxide under argon or nitrogen 
(H2O content < 10 ppm, Karl-Fischer titration). 
Reactions involving air or moisture sensitive reagents 
or intermediates were performed under argon or 
FULL PAPER HELVETICA CHIMICA ACTA  
9 
nitrogen in glassware which had been oven dried or 
dried by a heat gun under high vacuum. Concentration 
under reduced pressure was performed by rotary 
evaporation at 40 °C (unless otherwise specified). 
Yields refer to purified, dried and spectroscopically 
pure compounds. Analytical thin layer chromatography 
(TLC) was performed on Merck silica gel 60 F254 
plates (0.25 mm thickness) pre-coated with fluorescent 
indicator. The developed plates were examined under 
UV light and stained with ceric ammonium molybdate 
followed by heating. Flash chromatography was 
performed using silica gel 60 (230-240 mesh) from 
Fluka using a forced flow eluant at 0.3-0.5 bar 
pressure. 1H-NMR spectra were recorded on Varian 
Gemini Bruker DPX 400 MHz or Bruker DRX 600 MHz 
spectrometers at 298K or 348K in the indicated 
deuterated solvent, unless otherwise stated. Data are 
reported as follow: chemical shift (δ, ppm), multiplicity 
(s, singulet; d, doublet; t, triplet; q, quartet; m, multiplet 
or not resolved signal; br, broad signal; p, pseudo 
signal), coupling constant (J, Hz), integration. All 
signals were referenced to the internal solvent signal 
as standard (CDCl3, δ 7.26) or (DMSO-d6, δ 2.50) or 
(methanol-d4, δ 3.31). 13C-NMR spectra were recorded 
with 1H-decoupling on Varian Gemini 100 MHz or 
Bruker DPX 125 MHz spectrometers at 298K or 348K 
in the indicated deuterated solvent, unless otherwise 
stated. All signals were referenced to the internal 
solvent signal as standard (CDCl3, δ 77.0) or (DMSO-
d6, δ 39.52) or (methanol-d4, δ 49.00). IR spectra were 
recorded using a Varian 800 FT-IR ATR Spectrometer. 
The absorptions are reported in cm–1. Optical rotations 
[α]
  
D
T
 were measured at the sodium D line using a 1 mL 
cell with a 1 dm path length on a Jasco P-2000 digital 
polarimeter. The concentration c is given in g/100mL 
and the used solvent is CHCl3. All mass spectra 
(HRMS-ESI) were recorded by the Mass spectrometric 
Service of University of Bern on Sciex QSTAR Pulsar 
mass spectrometer using electrospray ionization. 
Compounds 1 and 2 were prepared according to 
literature procedure.[18,19]  
 
Preparation of compound 3: Boc-L-Thr(OBn)-D-
Ser(OBn)-L-Ser(OBn)-(3S)-THQ(OBn) chloride[20] (15 
mg, 14.5 µmol) was dissolved in MeOH (150 µL) and 
glacial acetic acid (30 µL) was added. The reaction 
vessel was flushed three times with argon and Pd/C 
(10 %) was added. The reaction vessel was flushed 
with hydrogen three times and the reaction mixture 
stirred at room temperature for four hours. The 
reaction mixture was then filtered over celite and the 
solvent evaporated under reduced pressure. The 
residual acid was coevaporated with chloroform to give 
target compound 3 (quant). [α] D
24
= -310.8 (C = 0.48 in 
H2O). FTIR (neat): ν = 3282, 2976, 2484, 1657, 1525 
cm-1. 1H-NMR (D2O, 300 MHz) 1.17-1.24 (m, 3H), 1.35 
(s, 6H), 1.41 (s, 3H), 1.95 (s, residual acetic acid), 2.9-
3.07 (m, 1H), 2.07-3.2 (m, 1H), 3.57 (m, 7H), 3.89 (m, 
4H), 4.04-4.24 (m, 2H), 4.38-4.52 (m, 2H), 4.56-4.7 (m, 
1H), 6.8 (s, 1H), 7.23 (s, 1H). HRMS calcd. for 
C26H42N5O10 (M)+: 584.2926, found: 584.2916. 
Preparation of compound 4: 
(S)-tert-Butyl 4-((S)-1-hydroxybut-3-en-1-yl)-2,2-
dimethyloxazolidine-3-carboxylate (8) was prepared by 
the addition of Garner aldehyde[20]  (7) into (R,R)-
Duthaler-Hafner reagent and allyl magnesium chloride 
complex following the literature procedure.[21a] The 
resulting alcohol was protected to afford the known 
(S)-tert-butyl 4-((S)-1-((tert-butyldimethylsilyl)oxy)but-3-
en-1-yl)-2,2-dimethyloxazolidine-3-carboxylate (9) and 
the spectra matched those reported.[21b] 
(S)-tert-butyl 4-((S)-3E-1-((tert-
butyldimethylsilyl)oxy)-5-oxopent-3-en-1-yl)-2,2-
dimethyloxazolidine-3-carboxylate (10): 
Crotonaldehyde (0.64 mL, 7.86 mmol, 6.0 eq) was 
added to a stirred solution of (S)-tert-butyl 4-((S)-1-
((tert-butyldimethylsilyl)oxy)but-3-en-1-yl)-2,2-
dimethyloxazolidine-3-carboxylate (9) (505 mg, 1.31 
mmol, 1.0 eq) and Grubbs-Hoveyda 2nd Generation 
Catalyst (16.4 mg, 26.2 mol, 0.02 eq) in DCM (15 mL). 
The resulting mixture was heated to reflux for 18 h and 
then cooled to room temperature. The solvent was 
removed in vacuo and the residue was purified by flash 
chromatography (SiO2, 15:1 pentane:EtOAc) to yield 
10 as colourless oil  (511 mg, 1.24 mmol, 94%). TLC: 
Rf = 0.3 (15:1 pentane:EtOAc). [α]
  
D
26
 = -39.5° (c = 1.0 
in CHCl3). FTIR (neat): ν = 2931, 1695, 1366, 1253, 
1170, 1074, 836, 776 cm-1. 1H NMR (600 MHz, DMSO, 
348K) δ = 9.60 (d, J = 7.7 Hz, 1H), 7.04 (ddd, J = 15.4, 
8.0, 6.6 Hz, 1H), 6.21 (dd, J = 15.6, 7.7 Hz, 1H), 4.42 – 
4.38 (m, 1H), 4.18 – 4.14 (m, 1H), 4.06 – 4.02 (m, 2H), 
2.64 – 2.59 (m, 1H), 2.53 – 2.46 (m, 1H), 1.63 (s, 3H), 
1.56 (s, 9H), 1.52 (s, 3H), 0.96 (s, 9H), 0.18 (s, 3H), 
0.14 (s, 3H). 13C NMR (151 MHz, DMSO, 348K) δ = 
192.8, 155.3, 151.4, 134.0, 93.7, 79.2, 69.5, 62.0, 59.6, 
34.0, 27.7, 25.7, 25.1, 22.5, 17.1, -5.0, -5.2. HRMS 
(ESI+) m/z calc’d for C21H40O5NSi [M+H]+: 414.2670, 
found 414.2666. 
 
(S)-tert-butyl 4-((1S,3R)-1-((tert-
butyldimethylsilyl)oxy)-3-hydroxy-5-methoxy-5-
oxopentyl)-2,2-dimethyloxazolidine-3-carboxylate 
(11): H2O2 (35% aq., 78 mL, 0.96 mmol, 1.2 eq) was 
added to stirred solution of 10 (331 mg, 0.80 mmol, 1.0 
eq) and (S)-(–)-α,α-diphenyl-2-pyrrolidinemethanol 
trimethylsilyl ether (27.4 mg, 0.08 mmol, 0.1 eq) in 
DCM (4 mL) at room temperature under argon 
atmosphere. Stirring was continued at room 
temperature for 16 h and then the solvent was 
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removed. The crude mixture was further dried under 
high vacuum (2 h, room temperature), the 
diastereoselectivity of the crude epoxy aldehyde was 
measured by 1H NMR, and the residue was then 
dissolved in DCM (4 mL). To the reaction mixture were 
then sequentially added 6,7-dihydro-2-
pentafluorophenyl-5H-pyrrolo[2,1-c]-1,2,4-triazolium 
tetrafluoroborate (14.4 mg, 0.04 mmol, 0.05 eq), 
methanol (162 L, 4.0 mmol, 5.0 eq) and triethylamine 
(68 L, 0.4 mmol, 0.5 eq). Stirring was continued for 
12 h at room temperature. The solvent was removed in 
vacuo and the residue was purified by flash 
chromatography (SiO2, 6:1 pentane:EtOAc) to yield the 
target compound 11 (inseparable mixture of 
diastereomers) as colourless oil  (298 mg, 0.64 mmol, 
81%). TLC: Rf = 0.3 (6:1 pentane:EtOAc). For mixture 
of diastereomers and rotamers: 1H NMR (400 MHz, 
CDCl3, 298K) δ = 4.43 – 4.26 (m, 1H), 4.23 – 4.06 (m, 
2H), 4.00 – 3.80 (m, 2H), 3.78 – 3.54 (m, 3H), 3.43 – 
3.17 (m, 1H), 2.59 – 2.35 (m, 2H), 1.71 – 1.62 (m, 2H), 
1.59 – 1.36 (m, 15H), 0.95 – 0.79 (m, 9H), 0.23 – 0.03 
(m, 6H). 13C NMR (101 MHz, CDCl3, 298K) δ = 172.3, 
152.7 and 152.1, 95.0 and 94.3, 80.3, 70.6 and 70.1, 
67.5, 63.1 and 62.8, 60.4 and 59.7, 51.6, 41.6 and 
41.3, 37.0, 28.6 and 28.4, 26.5 and 25.9, 25.7 and 
25.7, 23.9 and 22.4, 17.9 and 17.7, -3.8 and -4.1 and -
4.9 and -5.3. HRMS (ESI+) m/z calc’d for C22H44O7NSi 
[M+H]+: 462.2882, found 462.2876. 
 
(S)-tert-butyl 4-((5S,7R)-7-(2-methoxy-2-oxoethyl)-
2,2,3,3,9,9,10,10-octamethyl-4,8-dioxa-3,9-
disilaundecan-5-yl)-2,2-dimethyloxazolidine-3-
carboxylate (12): Lutidine (104 L, 0.88 mmol, 2.0 eq) 
and TBSOTf (152 L, 0.66 mmol, 1.5 eq) were 
successively added to a solution of 11 (203 mg, 0.44 
mmol, 1.0 eq) in DCM (2 mL) at -20 °C. The mixture 
was stirred at -20 °C for 1 h and then slowly warm to 
room temperature over 1 h. Then CH2Cl2 was added 
and the organic phase was washed 3× with citric acid 
(10%) and 2× with H2O, dried over Na2SO4 and filtered. 
The solvent was removed in vacuo and the residue 
was purified by flash chromatography (SiO2, 50:1 to 
30:1 pentane:EtOAc) to yield 12 as colourless oil  (12 
as major diastereomer 209 mg and 12′ as minor 
diastereomer 35 mg, 0.42 mmol overall, 96% overall 
yield). For 12: TLC: Rf = 0.30 (30:1 pentane:EtOAc). 
[α]
  
D
26
 = -55.3° (c = 1.0 in CHCl3). FTIR (neat): ν = 2955, 
2931, 1743, 1705, 1473, 1384, 1255, 1170, 837, 777 
cm-1. 1H NMR (600 MHz, DMSO-d6, 348K) δ = 4.31 – 
4.24 (m, 1H), 4.19 – 4.07 (m, 1H), 4.02 – 3.96 (m, 1H), 
3.95 – 3.91 (m, 1H), 3.91 – 3.86 (m, 1H), 3.59 (s, 3H), 
2.50 – 2.46 (m, 1H), 2.25 (dd, J = 14.5, 8.5 Hz, 1H), 
1.70 – 1.60 (m, 2H), 1.52 (s, 3H), 1.45 (s, 9H), 1.41 (s, 
3H), 0.89 (s, 9H), 0.85 (s, 9H), 0.11 (s, 6H), 0.05 (s, 
3H), 0.01 (s, 3H). 13C NMR (151 MHz, DMSO-d6, 
348K) δ = 170.6, 151.3, 93.6, 79.2, 67.1, 66.6, 62.0, 
59.3, 50.5, 40.9, 38.1, 27.7, 25.5, 25.2, 25.2, 22.6, 
17.1, 17.1, -4.5, -4.7, -5.3, -5.4. HRMS (ESI+) m/z 
calc’d for C28H58O7NSi2 [M+H]+: 576.3746, found 
576.3741. 
For minor diastereomer 12′: TLC: Rf = 0.33 (30:1 
pentane:EtOAc); [α]
  
D
26
 = -15.9° (c = 0.5 in CHCl3). 
FTIR (neat): ν = 2955, 2931, 1743, 1705, 1473, 1384, 
1255, 1170, 837, 777 cm-1. 1H NMR (600 MHz, DMSO-
d6, 348K) δ = 4.29 – 4.22 (m, 1H), 4.21 – 4.15 (m, 1H), 
3.98 – 3.93 (m, 1H), 3.93 – 3.87 (m, 2H), 3.59 (s, 3H), 
2.58 (dd, J = 14.9, 4.6 Hz, 1H), 2.45 (dd, J = 14.9, 7.3 
Hz, 1H), 1.70 (ddd, J = 14.3, 5.9, 2.1 Hz, 1H), 1.59 – 
1.54 (m, 1H), 1.53 (s, 3H), 1.45 (s, 9H), 1.41 (s, 3H), 
0.88 (s, 9H), 0.84 (s, 9H), 0.12 (s, 6H), 0.06 (s, 3H), 
0.03 (s, 3H). 13C NMR (151 MHz, DMSO-d6, 348K) δ = 
170.4, 151.5, 93.5, 79.1, 68.3, 67.6, 61.8, 59.7, 50.4, 
43.4, 38.6, 27.7, 25.7, 25.2, 25.2, 22.4, 17.1, 17.1, -4.4, 
-4.6, -4.8, -5.1. HRMS (ESI+) m/z calc’d for 
C28H58O7NSi2 [M+H]+: 576.3746, found 576.3749. 
 
(3R,5S,6S)-methyl 6-(2-(benzyloxy)benzamido)-3,5-
bis((tert-butyldimethylsilyl)oxy)-7-
hydroxyheptanoate (13): TFA (0.4 mL) was added 
drop-wise to a solution of 12 (118 mg, 0.20 mmol, 1.0 
eq) in DCM (2.0 mL) at 0 °C. The mixture was stirred 
at 0 °C for 1 h and then solvent was removed under 
reduced pressure keeping the temperature below 5 °C. 
Excess TFA was removed using high vacuum (3 h) at 
room temperature. The crude material 13′ was 
dissolved in dry DCM (1.0 mL) and used for next step 
without further purification. 
EDC.HCl (47 mg, 0.24 mmol, 1.2 eq), HOBt (33 mg, 
0.24 mmol, 1.2 eq) and NMM (68 L, 0.60 mmol, 3.0 
eq) were successively added to a solution of O-Bn-
salicylic acid (60 mg, 0.24 mmol, 1.2 eq) in DCM (1.0 
mL) at room temperature. The mixture was stirred at 
room temperature for 30 mins and then a solution of 
13′ in DCM (1.0 mL) was added. Stirring was 
continued for 20 h. The solvent was removed in vacuo 
and the residue was purified by flash chromatography 
(SiO2, 4:1 pentane:EtOAc) to yield 13 as colourless oil  
(99 mg, 0.15 mmol, 75%). TLC: Rf = 0.2 (4:1 
pentane:EtOAc). [α]
  
D
26
 = +9.9° (c = 1.0 in CHCl3). FTIR 
(neat): ν = 2954, 2930, 1729, 1601, 1487, 1451, 1295, 
1237, 1086, 887 cm-1. 1H NMR (400 MHz, CDCl3, 
298K) δ = 8.21 (d, J = 8.1 Hz, 1H), 8.18 (dd, J = 7.8, 
1.8 Hz, 1H), 7.45 – 7.29 (m, 6H), 7.05 (p t, J1 = J2 = 
7.5 Hz, 1H), 6.96 (d, J = 8.3 Hz, 1H), 5.28 (s, 2H), 4.39 
– 4.28 (m, 1H), 4.21 – 4.07 (m, 2H), 3.76 – 3.62 (m, 
2H), 3.49 (s, 3H), 2.54 (br s, 1H), 2.40 (d, J = 6.0 Hz, 
2H), 1.78 – 1.61 (m, 2H), 0.88 (s, 9H), 0.83 (s, 9H), 
0.11 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H). 
13C NMR (101 MHz, CDCl3, 298K) δ = 171.2, 166.4, 
156.6, 135.8, 132.8, 132.4, 128.8, 128.4, 127.2, 121.8, 
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121.4, 113.1, 70.9, 68.9, 66.2, 64.5, 54.0, 51.3, 43.1, 
41.5, 25.8, 25.7, 17.8, 17.8, -4.4, -4.5, -4.6, -4.8. 
HRMS (ESI+) m/z calc’d for C34H56O7NSi2 [M+H]+: 
646.3590, found 646.3580. 
 
(3R,5S,6S)-methyl 3,5-bis((tert-
butyldimethylsilyl)oxy)-7-hydroxy-6-(2-
hydroxybenzamido)heptanoate (4′): Compound 13 
(34.5 mg, 53.4 mol, 1.0 eq) was dissolved in dry 
CH3OH (2.0 mL), and glacial acetic acid (200 μL) was 
added. The reaction flask was flushed three times with 
argon, and then 10% Pd/C (11.4 mg, 10.7 mol, 0.2 
eq) was added. The reaction flask was flushed three 
times with H2, and the reaction mixture was stirred 2.5 
h at room temperature. The reaction mixture was then 
filtered over celite and solvent was removed in vacuo 
to yield 4′ as colourless oil  (29.5 mg, 53.1 mol, 99%). 
TLC: Rf = 0.5 (4:1 pentane:EtOAc). [α]
  
D
25
 = -14.4° (c = 
1.0 in CHCl3). FTIR (neat): ν = 3343, 2930, 2360, 1740, 
1636, 1536, 1362, 1254, 1097, 1038, 835, 776 cm-1. 
1H NMR (400 MHz, CDCl3, 298K) δ = 7.43 – 7.37 (m, 
1H), 7.31 (d, J = 7.9 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 
6.93 (d, J = 8.2 Hz, 1H), 6.89 – 6.81 (m, 1H), 4.28 (dd, 
J = 13.5, 6.5 Hz, 1H), 4.21 (dd, J = 8.1, 4.9 Hz, 1H), 
4.17 – 4.09 (m, 1H), 3.80 (dd, J = 10.5, 6.6 Hz, 1H), 
3.74 – 3.64 (m, 1H), 3.53 (s, 3H), 2.50 (dd, J = 14.7, 
5.0 Hz, 1H), 2.43 (dd, J = 14.7, 7.3 Hz, 1H), 2.09 (br s, 
1H), 1.82 – 1.68 (m, 2H), 0.94 (s, 9H), 0.88 (s, 9H), 
0.15 (s, 3H), 0.13 (s, 3H), 0.11 (s, 3H), 0.08 (s, 3H). 
13C NMR (101 MHz, CDCl3, 298K) δ = 171.1, 170.5, 
161.6, 134.4, 125.3, 118.8, 118.7, 114.0, 68.2, 66.1, 
63.6, 52.9, 51.5, 43.0, 42.1, 25.9, 25.7, 17.9, 17.8, -4.2, 
-4.5, -4.6, -4.9. HRMS (ESI+) m/z calc’d for 
C27H50O7NSi2 [M+H]+: 556.3120, found 556.3111. 
 
(3R,5S,6S)-methyl 3,5,7-trihydroxy-6-(2-
hydroxybenzamido)heptanoate (4): A solution of HCl 
(4 M) in dioxane (91 μL) was added drop-wise to a 
solution of 4′ (28.9 mg, 52.0 mol, 1.0 eq) in dry 
methanol (2.1 mL) at 0 °C. The mixture was stirred at 
0 °C for 1.5 h. All volatiles were removed under 
reduced pressure while keeping the solution 
temperature below 5 °C. The residue was further dried 
using high vacuum (1 h) at room temperature to 
provide the desired product as colorless oil (16.9 mg, 
51.6 mol, 99%). TLC: Rf = 0.3 (10:1 DCM:methanol). 
[α]
  
D
26
 = -23.7° (c = 1.0 in MeOH). FTIR (neat): ν = 3350, 
2955, 2363, 1721, 1636, 1546, 1443, 1307, 1256, 757 
cm-1. 1H NMR (400 MHz, MeOD, 298K) δ = 7.87 (dd, J 
= 8.1, 1.4 Hz, 1H), 7.41 – 7.33 (m, 1H), 6.95 – 6.88 (m, 
2H), 4.32 – 4.23 (m, 1H), 4.23 – 4.12 (m, 2H), 3.79 – 
3.68 (m, 2H), 3.62 (s, 3H), 2.52 (dd, J = 15.1, 4.8 Hz, 
1H), 2.44 (dd, J = 15.1, 8.0 Hz, 1H), 1.78 – 1.63 (m, 
2H). 13C NMR (101 MHz, MeOD) δ = 173.7, 170.3, 
160.1, 134.6, 130.0, 120.3, 118.1, 117.9, 69.1, 67.7, 
62.8, 55.8, 52.0, 43.2, 41.7. HRMS (ESI+) m/z calc’d 
for C15H23O7N [M+H]+: 329.1469, found 329.1456. 
Preparation of 3,5-epi-anachelin (5): Boc-L-
Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-
THQ(OBn)[18,20] (25 mg, 14.9 mol) was dissolved in 
dioxane (0.4 mL) and HCl·dioxane (4 M, 90 mol) was 
added at 0 °C. It was stirred one hour at this 
temperature and three hours at room temperature. The 
solvent was removed under reduced pressure and the 
product dried under high vacuum two hours. It was 
used without further purification. 
To a solution of (6S)-6-(2-benzyloxy-benzoylamino)-
(3S,5R)-3,5,7-tris-(tert-butyl-dimethyl-silanyloxy)-
heptanoic acid[18,20] (11 mg, 14.9 mol) in DMF (0.4 
mL) at –18 °C was added iBuOCOCl (1.9 L, 14.9 
mol) and NMM (5.4 L, 49.2 mol). The reaction 
mixture was stirred at this temperature for 20 min. 
Then H-L-Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-
THQ(OBn) (15 mg, 14.9 mol) dissolved in DMF (0.4 
mL) and NMM (3.3 L, 29.8 mol) was added 
dropwise at –18 °C and it was allowed to warm over 
four hours. The solvent was evaporated under reduced 
pressure and the residue taken up in AcOEt. It was 
washed 3x with H2O, and the resulting water extracted 
3x with AcOEt. The combined organic phases were 
dried over Na2SO4, filtered and evaporated under 
reduced pressure. FC (CH2Cl2 / MeOH : 10/1) gave 
(3S,5R,6S)-6-(benzyloxy-benzoylamino)-3,5,7-tris-
(tert-butyl-dimethyl-silanoxy)-heptanoic acid-L-
Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-THQ(OBn) (9 
mg, 5.4 mol, 36%) as colorless oil. 
(3S,5R,6S)-6-(Benzyloxy-benzoylamino)-3,5,7-tris-
(tert-butyl-dimethyl-silanoxy)-heptanoic acid-L-
Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-THQ(OBn) (9 
mg, 5.4 mol) was dissolved in CH3OH (350 L) and 
glacial acetic acid (30 drops) was added. The reaction 
vessel was flushed three times with Ar, and then Pd/C 
(10 %, 7 mg) was added. The reaction vessel was 
three times flushed with H2 and the reaction mixture 
was stirred 2.5 hours at RT. The reaction mixture was 
then filtered over celite and the solvent removed under 
reduced pressure. The residue was dissolved in cold 
MeOH containing 1% HCl (1mL) and the solution 
stirred for four hours at 0°C. Then the solvent was 
evaporated under reduced pressure and the residual 
acid was coevaporated three times with chloroform. It 
was dissolved in deuterated water and lyophilized to 
give 3,5-epi-anachelin (5) (2.3 mg, 2.9 mol, 55%) as 
light yellow fluffy powder. [α] D
25
 = - 60.0° (C = 0.1 in 
H2O). FTIR (neat): ν = 3679, 1643, 1609, 1571, 1537 
cm-1. HRMS calcd. for C35H51N6O14 (M)+: 779.3458, 
found: 779.3448. 1H-NMR data, see supporting 
information. 
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Preparation of 3,5,6-epi-anachelin (6): Boc-L-
Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-
THQ(OBn)[18,20] (38 mg, 35.4 mol) was dissolved in 
dioxane (0.6 mL) and HCl·dioxane (4 M, 100 mol) 
was added at 0 °C. It was stirred 1 hour at this 
temperature and 3 hours at RT. The solvent was 
removed under reduced pressure and the product 
dried under high vacuum 2 hours. It was used without 
further purification. To a solution of (6R)-6-(2-
benzyloxy-benzoylamino)-(3S,5R)-3,5,7-tris-(tert-butyl-
dimethyl-silanyloxy)-heptanoic acid[18,20] (24 mg, 
32.2 mol) in DMF (0.6 mL) at –18 °C was added 
iBuOCOCl (4.2 L, 32.2 mol) and NMM (13 L, 113 
mol). The reaction mixture was stirred at this 
temperature for 20 min. Then H-L-Thr(OBn)-D-
Ser(OBn)-L-Ser(OBn)-(3S)-THQ(OBn) (36 mg, 35.4 
mol) dissolved in DMF (0.5 mL) and NMM (7 L, 38 
mol) was added dropwise at –18 °C and it was 
allowed to warm over four hours. The solvent was 
evaporated under reduced pressure and the residue 
taken up in AcOEt. It was washed three times with H2O, 
and the resulting water extracted three times with 
AcOEt. The combined organic phases were dried over 
Na2SO4, filtered and evaporated under reduced 
pressure. FC (CH2Cl2 / MeOH : 10/1) gave 
(3S,5R,6R)-6-(benzyloxy-benzoylamino)-3,5,7-tris-
(tert-butyl-dimethyl-silanoxy)-heptanoic acid-L-
Thr(OBn)-D-Ser(OBn)-L-Ser(OBn)-(3S)-THQ(OBn) (27 
mg, 16 mol, 50%) as colorless oil. 
This compound (9 mg, 5.3 mol) was dissolved in 
CH3OH (350 L) and glacial acetic acid (30 drops) was 
added. The reaction vessel was flushed three times 
with Ar, and then Pd/C (10 %, 7 mg) was added. The 
reaction vessel was three times flushed with H2 and 
the reaction mixture was stirred 2.5 hours at RT. The 
reaction mixture was then filtered over celite and the 
solvent removed under reduced pressure. The residue 
was dissolved in cold MeOH containing 1% HCl (1 mL) 
and the solution stirred for 4 hours at 0 °C. Then the 
solvent was evaporated under reduced pressure and 
the residual acid was co-evaporated three times with 
chloroform. It was dissolved in deuterated water and 
lyophilized to give 3,5,6-epi-anachelin (6) (2.1 mg, 2.6 
mol, 50%) as light yellow fluffy powder. [α] D
25
= - 26.7° 
(C = 0.12 in H2O). FTIR (neat): ν = 3679, 1638, 1530 
cm-1. HRMS calcd. for C35H51N6O14 (M)+: 779.3458, 
found: 779.3447. 1H-NMR data see supporting 
information. 
Biological assays. The blue-green-colored unicellular 
cyanobacterium Microcystis aeruginosa PCC 7806 
was provided by R. Rippka (Pasteur Culture Collection, 
Paris, France); the unicellular green alga Kirchneriella 
contorta SAG 11.81 was provided by the Culture 
Collection of Algae at the University of Göttingen, 
Germany. Both strains were grown in Erlenmeyer 
flasks on a cyanobacterial medium as described by 
Jüttner and co-workers[35] on 10 µM Fe-citrate at 
20 °C under continuous light from fluorescent tubes (7 
µmol m-2 s-1). For the inhibition growth assays, the 
microorganisms were transferred into commercial 96-
well microtiter plates endowed with 180 µl 
cyanobacterial medium or 180 µl Fe-limited 
cyanobacterial medium (0.1 µM Fe-citrate). 20 µl cell 
suspension were added to each well having then an 
OD675 nm of approximately 0.1 at the beginning of the 
experiment. The plates were incubated at 20 °C under 
continuous light from fluorescent tubes (7 µmol m-2 s-1). 
Measurements of OD675 nm were performed daily on 
an Absorbance Microplate Reader (Spectra Max 190; 
Molecular Devices Corporation; Sunnyvale, CA, USA). 
Anachelin, the synthesised fragments, and the 
diastereoisomers were added on the 5th day in 20 µl 
dissolved in H2O. Each compound was tested in five to 
six concentrations, ranging from 8 nM to 90 µM (end 
concentrations in the wells).  The OD675 nm was 
chosen for the determination of the in vivo absorption 
of chlorophyll a. To test the validity of this method, 
dilutions were prepared ranging from an OD675 nm of 
0.01 to 1.2 (M. aeruginosa) and of 0.01 to 1.8 (K. 
contorta). The R2 values of the linear regression 
curves were 0.998 and 0.999 respectively. 
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